Related Experiment Video
Updated: Jan 9, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
A Simplified Frailty Measure Improves Risk Stratification in Patients Undergoing Percutaneous Mitral Valve Repair
Clemens Metze1, Elric Zweck2, Christos Iliadis1
1Department of Cardiology, Heart Center Cologne, University of Cologne, Faculty of Medicine and University Hospital, Cologne, Germany.
Objective:
The aim of this study was to examine frailty measures for risk prediction in patients undergoing percutaneous mitral valve repair (PMVR).
Background:
Performance of current risk prediction models based on organ morbidity is only moderate.
Methods:
The frailty domains exhaustion, slowness, inactivity, weakness, and unintentional weight loss were prospectively assessed in patients undergoing PMVR. The association with mortality and heart failure hospitalization (HFH) during a median follow-up of 506 days was examined and relevant domains were assessed for additive predictive performance over the MitraScore.
Results:
Five hundred twenty-four patients were included in the study (mean age [SD]: 77 (9) years, 54.6% male). The risk of mortality and mortality/HFH were significantly increased in patients with exhaustion (hazard ratio: 2.24 [95% CI: 1.63-3.08]/1.83 [1.21-2.77]), slowness (2.74 [1.75-4.30]/1.92 [1.34-2.75]), inactivity (1.96 [1.26-3.05]/1.61 [1.12-2.31]) and weakness (1.83 [1.12-2.96]/1.34 [0.92-1.95]), but not in patients with weight loss (1.24 [0.80-1.92]/1.12 [0.78-1.61]). A simplified frailty (S-frailty) measure derived from the domains exhaustion and slowness was associated with mortality (4.45 [2.42-8.19]) and mortality/HFH (2.60 [1.64-4.13]) independently of clinical risk factors and the MitraScore, respectively. Prediction of mortality by the MitraScore was significantly improved when adding S-frailty (Harrell's C 0.645 vs. 0.700, p = 0.002). Classification of 1-year mortality risk by the MitraScore improved when adding S-frailty (net reclassification index 0.21, p = 0.012 and integrated discrimination index 0.07, p < 0.001).
Conclusions:
A simplified frailty measure comprising self-reported exhaustion and gait speed significantly improved risk prediction in patients undergoing PMVR. Assessment of frailty measures should be part of the decision-making process and multiparametric risk scores in patients with severe mitral regurgitation.
Insights
A simplified frailty measure, including exhaustion and slowness, significantly improved risk prediction for mortality and heart failure hospitalization in patients undergoing percutaneous mitral valve repair (PMVR). This frailty assessment should be integrated into clinical decision-making for severe mitral regurgitation.
Area of Science:
- Cardiology
- Geriatrics
- Clinical Risk Prediction
Background:
- Current risk prediction models for percutaneous mitral valve repair (PMVR) based on organ morbidity have moderate performance.
- There is a need for improved risk stratification in patients undergoing PMVR.
Purpose of the Study:
- To examine the utility of frailty measures for risk prediction in patients undergoing PMVR.
- To assess the additive predictive performance of frailty domains over the existing MitraScore.
Main Methods:
- Prospective assessment of frailty domains (exhaustion, slowness, inactivity, weakness, weight loss) in patients undergoing PMVR.
- Examination of the association between frailty domains and mortality/heart failure hospitalization (HFH).
- Evaluation of a simplified frailty (S-frailty) measure for its predictive performance compared to the MitraScore.
Main Results:
- Exhaustion, slowness, inactivity, and weakness were significantly associated with increased risk of mortality and HFH.
- A simplified frailty (S-frailty) measure derived from exhaustion and slowness independently predicted mortality and HFH.
- Adding S-frailty to the MitraScore significantly improved the prediction of mortality and 1-year mortality risk.
Conclusions:
- A simplified frailty measure combining exhaustion and gait speed enhances risk prediction in PMVR patients.
- Frailty assessment should be incorporated into clinical decision-making and risk scores for patients with severe mitral regurgitation.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Stenosis IV: Nursing Management
Mitral Valve Prolapse I: Introduction

